Please assess the completion status of the following clinical trial:

Trial Title: Change in Plaque Characteristics With Atorvastatin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI.~* plasma LDL cholesterol levels : \>=100mg/dL and ≤160mg/dL~* at least one atherosclerotic lesion of \>25% stenosis other than culprit lesions of current ACS~Exclusion Criteria:~* Patients who will undergo coronary bypass surgery.~* Patients with major complications during treatment of culprit coronary lesions.~* Patients with an atherosclerotic lesion with \>50% stenosis at a left main trunk.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Atorvastatin 20mg
- 2 (Type: ACTIVE_COMPARATOR): atorvastatin 5mg

Based on this trial design, predict the completion outcome and termination type (if applicable).